Completion of Phase 2 HIV-1 Clinical Trials 9 March 2023 by Audrey Thomson Completion of Phase 2 HIV-1 Clinical Trials
Presentation of BIT225 COVID-19 Data at International Conference 21 February 2023 by Audrey Thomson Presentation of BIT225 COVID-19 Data at International Conference
Half-year Report 31 December 2022 17 February 2023 by Audrey Thomson Half-year Report 31 December 2022
Notice of Cessation of Securities 7 February 2023 by Audrey Thomson Notice of Cessation of Securities
Report on Activities for the Quarter ended 31 December 2022 31 January 2023 by Audrey Thomson Report on Activities for the Quarter Ended 31 December 2022
Quarterly Report 31 December 2022 31 January 2023 by Audrey Thomson Quarterly Report 31 December 2022
